Company Filing History:
1 out of 18 
1 out of 32 
1 out of 1 Years Active: 2025
Title: Etienne Brochot: Innovator in Monoclonal Antibody Development
Introduction
Etienne Brochot is a notable inventor based in Amiens, France. He has made significant contributions to the field of medical research, particularly in the development of monoclonal antibodies. His work focuses on detecting infections caused by the BK polyomavirus, which can have serious implications for human health.
Latest Patents
Etienne Brochot holds a patent for an innovative monoclonal antibody that targets the VP-1 protein of the BK polyomavirus. The patent, titled "Antibody targeting the VP-1 protein, fragments thereof, and uses of same for detecting infection with the BK polyomavirus," describes a new method for detecting infections. This antibody is capable of recognizing various serotypes of the VP-1 protein, including Ia, Ib2, II, III, and IV. He has 1 patent to his name.
Career Highlights
Throughout his career, Etienne has worked with esteemed institutions such as Université de Tours and Université de Picardie Jules Verne. His research has contributed to advancements in virology and immunology, particularly in understanding and detecting viral infections.
Collaborations
Etienne has collaborated with several professionals in his field, including Antoine Touze and Pauline Gaboriaud. These collaborations have enhanced his research and contributed to the development of effective diagnostic tools.
Conclusion
Etienne Brochot's work in developing monoclonal antibodies represents a significant advancement in the detection of viral infections. His contributions to the field continue to impact medical research and diagnostics.